OBJECTIVE: Some studies have shown a more rapid gastric emptying in obese subjects. Six to twelve months after jejunoileal bypass (JIB) neurotensin (NT) and enteroglucagon have been shown to be elevated after food intake. These hormones, together with peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) have been implicated in the reduction of upper gastrointestinal motility seen after infusion of nutrients into the ileum. AIM: To study if the postprandial gut hormone pattern and gastric emptying is altered 20 y after JIB. SUBJECTS: Seven subjects operated with JIB a mean (s.d.) 20 AE 3 y ago, with a BMI of 44 AE 4 kg/m 2 at the time of surgery and 31 AE 4 at present. For comparison seven sex-matched non-operated obese controls (BMI 43 AE 3) were studied. METHODS: Serial blood samples were obtained every 10 min after intake of a 280 kcal meal. Radioimmunoassays for motilin, cholecystokinin (CCK), NT, PYY and GLP-1 were performed. Gastric emptying of a solid meal was studied using a radioactively labelled omelette (of 310 kcal) for 120 min). RESULTS: After JIB postprandial motilin, CCK, NT, PYY and GLP-1 were elevated compared to non-operated obese subjects. Similarly, basal levels of CCK, motilin, GLP-1 and PYY were elevated in the operated group. No difference was observed in the rate of gastric emptying between the two groups. CONCLUSION: Both fasting and postprandial gut hormone levels are elevated 20 y after JIB. The impact of long-term rapid stimulation of the ileum and subsequent raised gut hormone levels on gastric emptying is not clear.
Introduction
After food intake a cascade of hormones are released from different parts of the gastrointestinal tract. These hormones in¯uence functions that promote digestion of nutrients through actions on motility, secretion and absorption. When rapid stimulation of the lower small intestine with nutrients occurs, the normal release of gut hormones is altered. Thus, after jejunoileal bypass (JIB), where 90% of the small bowel is bypassed, the postprandial levels of gastrin, neurotensin (NT), enteroglucagon and cholecystokinin (CCK) are elevated, while motilin, gastric inhibitory peptide and insulin are reduced. 1±5 Also, infusions of different nutrients directly into the ileum have been shown to cause elevations of the distal small intestine hormones enteroglucagon and NT. 6 Concomitantly with the release of these hormones there is a reduction in the rate of gastric emptying and small bowel transit. 7 This action has been named the`ileal brake'. Along with infusion of nutrients into the ileum, hunger and food intake decrease. 8 However, it is not clear whether enteroglucagon or NT mediate the alterations in upper gut motility seen after stimulation of the distal small bowel with nutrients. Other distal small bowel hormones, such as peptide YY (PYY) and glucagon-like peptide-1 are other possible candidates that may mediate thè ileal brake'. 9, 10 Previous studies on the release of gastrointestinal hormones after JIB have been performed with short follow-up. 1±5 Little is known about the effects of longterm stimulation of the ileum with nutrients in man. The aim of this study was therefore to investigate the postprandial release of CCK, motilin, NT, GLP-1 and PYY in subjects 20 y after JIB for the treatment of morbid obesity. In addition, gastric emptying of a solid meal was investigated to assess the long-term effects on gastric motility after JIB.
Materials and methods

Subjects and controls
Seven subjects (six females) operated with JIB 20 AE 3 y ago were examined. The mean preoperative BMI was 44 AE 4 kg/m 2 . The BMI and age at the time of this study was 31 AE 4 and 51 AE 4 y, respectively. As controls a group of sex-matched non-operated obese subjects with a similar BMI to the preoperative values of study group (43 AE 3); and an age of 40 AE 12 were used ( Table 1) . The gastric emptying and hormone studies were performed within one month of each other. The control subjects were recruited from the waiting list for bariatric surgery at Danderyd Hospital. None of the patients or controls suffered from gastrointestinal disease, diabetes mellitus or took medications known to affect gastrointestinal motility. All subjects gave their informed consent to participate. The study was approved by the Karolinska Hospital Ethics and Isotope Committees.
Surgical procedure and clinical follow-up
Four patients were operated with an end-to-side jejunoileal bypass originally described by Payne and DeWind, 11 two patients with an end-to-end jejunoileal bypass with ileocecal anastomosis of the blind loop, 12 and one patient with an end-to-end anastomosis with a anastomosis of the proximal end of the blind loop to the gallbladder 13 ( Table 1) . None of the obese subjects have later had revisional surgery. One patient was twice operated for intestinal obstruction and one with a salpingoophorectomy due to extrauterine pregnancy. Two of the patients were treated for renal stones in the postoperative period. The patients reported between 1±4 loose stools per day and none showed elevations of the liver function tests or altered electrolyte balance at the time of investigations for this study.
Gastrointestinal hormones
After an overnight fast the subjects were given a 280 kcal standardised meal (9 g fat, 35 g carbohydrate and 14 g protein) consisting of Swedish meatballs and mashed potatoes (Weight Watchers food, Helsingborg, Sweden). Blood samples were collected in 10 ml heparinised tubes 10 min before and at the start of the meal, and then every 10 min after the meal for 60 min. The blood samples were placed on ice and centrifuged at 4 C at 3000 rpm for 10 min. Plasma was collected and stored at 720 C before extraction procedures and radioimmunoassay (RIA). All samples were analysed by RIA, in duplicate, in one series and mean values were used for calculation.
For the analysis of motilin, NT and CCK the frozen plasma samples were thawed and were extracted onto Sep-Pak C-18 cartridges (Water Associates, Milford, MA, USA).
Motilin-like immunoreactivity (MT-LI) was analysed using antiserum MOT4 raised against conjugated porcine motilin. HPLC puri®ed 125 -labelled was used as radioligand, and porcine motilin as calibrator. The antiserum crossreacted less than 0.1% with pancreatic polypeptide, gastrin, vasoactive intestinal peptide, enteroglucagon, NT, neuropeptide Y, calcitonin gene-related peptide, substance P, neurokinin A, atrial natriuretic peptide, insulin, C-peptide and CCK. The detection limit of the assay was 3.9 pmol/L and the intra-and interassay coef®cients of variation were 7 and 10% respectively at 50 pmol/L.
Neurotensin-like immunoreactivity (NT-LI) was analysed using antiserum H which reacts with NT(4±13) (18%) (67%) and NT(9±13) (15%) but not with N-terminal fragments of NT. The detection limit of the assay was 8 pmol/L. Intra-and interassay coef®cients were 8 and 13% respectively. 14 CCK was analysed using antiserum against CCK-8 with a crossreactivity against gastrin of 0.5%. The detection limit of the assay was 0.3 pmol/L. Intra-and interassay coef®cients of variation were 5.5 and 13.7%, respectively (Euro-Diagnostica, Malmo È, Sweden).
Plasma samples of GLP-1 and PYY were extracted with ethanol (®nal concentration 70% vol/vol). GLP-1 was measured using previously described RIA 15 the antiserum of which (code no. 89390) is directed against the amidated C-terminus of GLP-1. The assay, therefore, mainly measures GLP-1 of intestinal origin. The intra-and interassay coef®cients of variation were 6 and 15%, respectively. Gut hormones and gastric emptying 20 years after JIB E Na Èslund et al RIA of PYY in plasma was performed using antiserum code no. 8412-2II (a gift from R. Ha Êkanson, Dept of Pharmacology, University of Lund, Lund, Sweden) raised in rabbits against synthetic porcine PYY 1-36 (Peninsula Europe, Merseyside, UK) as previously described. 16 The antiserum crossreacts 100% with human PYY. The intra-and interassay coef®cients of variation were 5 and 15%, respectively.
Scintigraphic gastric emptying
The scintigraphic gastric emptying test of a solid meal has been described in detail elsewhere. 17 In short, subjects were studied after an overnight fast using a 310 kcal omelette with 12±15 MBq 99m Tc-labelled macroaggregated albumin (Pulmonate TM , Amersham International plc, Little Chalfont, UK). Anterior and posterior one-min acquisitions were performed with the patient in sitting position. Registration was undertaken every ®ve min during the ®rst 50 min and thereafter every ten minutes during the remaining 70 min.
The following parameters were calculated:
(1) Lag-phase, de®ned as the time period from termination of meal until 90% of radioactivity remained in the stomach. (2) Gastric emptying rate, de®ned as %/min during the linear slope after termination of the lag-phase. (3) Half-emptying time (T 50 ), de®ned as the time for 50% emptying of gastric contents after termination of the meal. (4) Gastric retention at 60, 90, 120 min, de®ned as the % radioactivity remaining in the stomach at the respective time points.
Data analysis
Values are given as mean AE s.d. Kaplan-Meier plots and the Log-Rank test were used to illustrate and compare the results of the lag phase and T 50 . 17 The unpaired Student's t-test was used for the analysis of BMI, gastric emptying rate, retention at 60, 90 and 120 min. A multivariate analysis test (MANOVA) with repeated measures was used to compare the results of the hormone analyses and single time points were compared with the Tukey HSD posttest. A P value less than 0.05 was considered statistically signi®cant.
Results
Gut hormone levels
In general, postprandial CCK, motilin, NT, GLP-1 and PYY were all elevated 20 y after JIB than in nonoperated obese subjects (Figures 1 and 2) .
Fasting levels of CCK, motilin, GLP-1 and PYY were higher in the JIB group than in non-operated obese controls, at both 7 10 and 0 min; while NT was higher in the JIB group than in the obese controls, at 710 but not at 0 min (Figures 1 and 2) .
A signi®cant postprandial rise from fasting levels was only seen for CCK in the JIB group and for none of the hormones studies in the non-operated control group. The s.d. was rather large which may account for this lack of a statistically signi®cant postprandial rise of the studied gut hormones.
Gastric emptying
The parameters of gastric emptying were similar for JIB operated and non-operated obese controls ( Table  2) .
Discussion
This 20 y follow-up study, in humans operated for morbid obesity with JIB, demonstrates that the gastrointestinal hormones CCK, motilin, NT, GLP-1 and PYY are elevated after a test meal. Also, basal levels in the fasting state were elevated for CCK, motilin, GLP-1 and PYY. Furthermore, similar gastric empty- Figure 1 Mean AE s.d. postprandial plasma motilin and cholecystokinin (CCK) values for seven non-operated obese control subjects and seven subjects 20 y after jejunoileal bypass (JIB) for morbid obesity.
* P`0.05, MANOVA.
Gut hormones and gastric emptying 20 years after JIB E Na Èslund et al 389 ing rates were found between subjects 20 y after JIB and in non-operated obese controls. The rise of gut hormone levels shown at short-term follow-up after JIB is consistent with the known distribution of these hormones. Upper gastrointestinal hormones such as motilin are reduced and distal gut hormones such as NT, enteroglucagon are elevated.
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The hormone pattern seen in this study differs partly from perviously published ®ndings with short-term follow-up. In this study, fasting levels of CCK, motilin, GLP-1 and PYY were elevated, the same has previously been shown for enteroglucagon. 2, 5 Also, the postprandial levels of motilin were elevated in contrast to a previous study where the levels were reduced. 2 It is possible that the altered gut hormone pro®le seen 20 y after JIB can be attributed to the known changes of small bowel morphology and function seen after the JIB. Several reports, both in man 18, 19 and in animal studies, 20 have shown a marked hyperplasia, dilation and lengthening of the intact bowel, with a corresponding hypoplasia of the bypassed segment. It has been suggested that enteroglucagon is a likely hormonal candidate mediating part of the observed hyperplasia. 21 Enteroglucagon was not measured in this study but has been previously shown to be secreted in parallel with GLP-1 22 which was elevated in this study. In a study by Buchanan and co-workers 23 of a modi®cation of JIB, ileogastrostomy, it was found that the number of CCK-immunoreactive cells increased in biopsies from the duodenum and jejunum; and GIP-, secretion-, motilin-and somatostatinimmunoreactive cells had increased in the jejunum three months after surgery. Also, since the ileum of the bypassed segment is anastomosed to the stomach, biopsies could be taken from the ileum of the bypassed segment. Cells immunoreactive to enteroglucagon, but not to neurotensin or somatostatin increased signi®cantly. This suggests that not only immunoreactive cells of the intact small bowel, but also from the bypassed segment, may have contributed to the elevated levels of gut hormones seen after JIB.
Not only an increased release of peptides, but also a reduced clearance may be responsible for the elevated levels of peptides seen after long-term follow-up of JIB. Although none of the subjects in the JIB group in this study showed signs of liver dysfunction, one potential complication of JIB is liver failure. CCK is metabolised in the liver and therefore changes in basal and postprandial levels may be due to different rates Figure 2 Mean AE s.d. postprandial plasma neurotensin, peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) values for seven non-operated obese control subjects and seven subjects 20 y after jejunoileal bypass (JIB) for morbid obesity.
* P`0.05, MANOVA. Gut hormones and gastric emptying 20 years after JIB E Na Èslund et al of clearance after JIB. Motilin is mainly metabolised in the kidney, NT in the kidney and gut 24 and GLP-1 is rapidly degraded in plasma and in the kidneys. 25 It is possible that having a bypassed segment may in¯uence the metabolism of these hormones. However, it would seem more likely that the observed elevated fasting levels of GLP-1, motilin and PYY are due to an increased cell mass producing of these peptides rather than a reduced breakdown.
We have shown that when using the Kaplan-Meier plot and log rank test, which we believe better compares the time dependent variables of gastric emptying than the more static Student's t-test, obese subjects seem to empty a solid meal faster than normal weight controls. 17 Also, in obese subjects nine months after JIB, gastric emptying is signi®cantly slower compared to before surgery and not different from that of age-and sex-matched controls. Concomitantly with this the postprandial levels of GLP-1, PYY and neurotensin are elevated (unpublished data). NT, GLP-1 and PYY have all been implicated as mediating the ileal brake re¯ex on upper gut motility when nutrients are infused into the ileum. 6, 26 In the light of this, and the elevated levels of gut hormones shown in this study, one would expect to ®nd a slower rate of gastric emptying in the obese subjects operated with JIB 20 years ago than in non-operated obese controls.
However, this assumption could not be shown in the present study as we found similar rates of gastric emptying in the JIB operated and the non-operated obese subjects. Therefore, it is possible that the mechanisms by which the ileum regulates upper gut motility when it is exposed to an abnormal nutrient stimulus over a prolonged time period can be desensitised. Further support for this assumption can be found in animal studies. When rats are subjected to chronic intermittent infusion of lipids three times a week the initially observed delay in gastric emptying and small intestinal transit is abolished. 27 It is possible that this adaption of the intestine to a long-term stimulus with various nutrients may be important also in the development of obesity and suggests a mechanism by which the observed faster gastric emptying of a solid meal 17 in obese subjects can be explained.
In man, it is not clear what impact the elevated basal or postprandial levels of the examined gut hormones exerts on food intake. Several studies have shown that food intake is decreased after JIB 28, 29 with a reduced preference for sugar. 28 Stimulation of the ileum with nutrients decreases food intake 8, 30 and some of the hormones that are elevated after JIB have been shown to decrease food intake in man and animals. 31 It is therefore tempting to speculate that the elevated gut hormone levels seen in these patients 20 y after JIB contribute to a decreased food intake, either by acting peripherally on the gut or directly on central receptors, resulting in a maintained weight control for these patients.
Conclusions
This study demonstrates that 20 y after JIB for morbid obesity postprandial motilin, CCK, NT, PYY and GLP-1 are higher than in non-operated obese controls. Also CCK, motilin, GLP-1 and PYY are elevated in the fasting state 20 y after JIB. The effect of the elevation of these hormones on gastric emptying of a solid meal is complex. Although JIB has largely been abandoned for the treatment of morbid obesity, these results may be of importance for our understanding of adaptive responses of the small intestine after extensive resections leading to the short bowel syndrome. These observations might also be a basis for other types of`intestinal endocrine' surgery or hormonal treatment for obesity.
